Executive Profile*

Nancy A. Simonian M.D.

AgeTotal Calculated CompensationThis person is connected to 25 board members in 2 different organizations across 4 different industries.

See Board Relationships


Dr. Nancy A. Simonian, M.D., has been the Chief Executive Officer at Syros Pharmaceuticals, Inc. since July 2012 and serves as its President. Dr. Simonian served as the Chief Medical Officer of Clinical, Medical & Regulatory Affairs at Millennium Pharmaceuticals, Inc. She served as the Chief Medical Officer of Millennium Pharmaceuticals Inc. since 2006. While at Millennium, Dr. Simonian has built a strong clinical development organization which effectively executes on ...

Read Full Background

Corporate Headquarters*

40 Landsdowne Street
Cambridge, Massachusetts 02139

United States

Phone: 617-761-4741
Fax: 617-374-7788

Board Members Memberships*

Chief Executive Officer, President and Director


Princeton University
Perelman School of Medicine at the University of Pennsylvania

Other Affiliations*

Annual Compensation*

Total Annual Compensation$425,000

Stock Options*

All Other Compensation$270
Exercisable Options90,681
Unexercisable Options329,987
Total Number of Options420,668

Total Compensation*

Total Annual Cash Compensation$425,270
Total Short Term Compensation$425,000
Other Long Term Compensation$270
Total Calculated Compensation$1,148,518
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.